Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study.
Georgakopoulou VE, Basoulis D, Voutsinas PM, Makrodimitri S, Samara S, Triantafyllou M, Eliadi I, Karamanakos G, Papageorgiou CV, Anastasopoulou A, Bitsani A, Kampouropoulou O, Eleftheriadou I, Gkoufa A, Spandidos DA, Papalexis P, Sipsas NV.
Georgakopoulou VE, et al. Among authors: eleftheriadou i.
Exp Ther Med. 2022 Oct 20;24(6):724. doi: 10.3892/etm.2022.11660. eCollection 2022 Dec.
Exp Ther Med. 2022.
PMID: 36340609
Free PMC article.